Morgan Joseph Upgrades Myriad Genetics (MYGN) to Hold; Expect Positive Sales
Tweet Send to a Friend
Morgan Joseph upgrades Myriad Genetics (Nasdaq: MYGN) from Sell to Hold.
Morgan analyst says, "Following the past two disappointing quarterly ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Morgan analyst says, "Following the past two disappointing quarterly ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
